Tzlil Hadass

Chief Revenue Officer at Science Exchange | GTM Advisor | Angel Investor

📍 United States🔄 Updated September 2026💼 1 investments📅 4 years investing🗓 Last invested Jan 2022
VC🌍 United States
1
Total investments
0
Early stage
0
Mid stage
0
Late stage
4y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jan 2022
This is a catchall company for the doers, the thinkers, and the innovators.
Experience · 3 entries
All (3)
Investments (1)
2022
Investor
Jan 2022
This is a catchall company for the doers, the thinkers, and the innovators.
2021
Chief Revenue Officer
Nov 2021
Science Exchange is the first purchasing and supplier orchestration platform for life sciences companies. We’re on a mission to streamline and modernize the way R&D organizations and suppliers work together. Our platform harmonizes purchasing, supplier management, and payment processing through one platform and digital marketplace. Whether using our network of 3,800 suppliers with established contracts or syncing existing ones, a simple intake process enables scientists to purchase the services and products they need while workflows and integrations guide them through approvals and compliance requirements. Science Exchange ensures supplier data integrates into ELNs and the secure transfer of large files to enhance supplier collaboration. The platform also employs an automated payment system to validate all invoices and provide prompt supplier payment. The world’s top life sciences companies, including BMS, AbbVie, Gilead, and Astellas, rely on Science Exchange to help accelerate their research, automate manual processes, and advance their programs faster.
Limited Partner
Aug 2021
FourSight is boutique Family Office that seeks to identify value in underserved, or under-capitalized business and markets. We invest across alternative asset classes including direct investments, fund commitments, and real estate.